Hyro, a New York City-based AI agent platform for healthcare, said it has raised $45 million in strategic growth funding to accelerate adoption of its technology.
The funding round was led by Healthier Capital and included participation from Norwest, Define Ventures and existing investors, according to an Oct. 21 news release. Strategic investors included Cincinnati-based Bon Secours Mercy Health and ServiceNow Ventures. The raise doubles Hyro’s valuation and brings its total funding to $95 million.
Hyro said its AI platform is deployed across more than 45 health systems and supports over 30 million patients. The company’s hybrid architecture, which combines large and small language models with healthcare-specific knowledge graphs, can resolve up to 85% of routine patient interactions, such as scheduling and prescription management.
